By Toni Clarke
(Reuters) - The U.S. Food and Drug Administration said on Friday it has approved a vaccine made by GlaxoSmithKline Plc for use in the event of an H5N1 bird flu epidemic.
The vaccine, Pandemrix, will be added to the national stockpile and will not be available for commercial use, the FDA said.
It is the first H5N1 vaccine approved in the United States to contain an adjuvant, or booster, that turbo-charges the body's immune response to the vaccine. http://innerrank.com/story.php?title=topic-men-are-constantly-discussing-women%E2%80%99s-breasts-|-persatuan-diabetes-indonesia"This vaccine could be used in the event that the H5N1 avian influenza virus develops the capability to spread efficiently from human to human, resulting in the rapid spread of disease across the globe," Dr. Karen Midthun, director of the FDA's biologics division, said in a statement. http://rapprint.com/story.php?title=topic-breast-cancer-causes-and-risk-factors-|-cod4-es-2
The FDA approved the vaccine for use in people over the age of 18 who are at increased risk of exposure to the virus. It would be distributed by public health officials if needed.
The approval comes amid some uncertainty over the safety of modern adjuvants such as the one used in GSK's bird flu vaccine.
However, there are no effective traditional vaccines against bird flu. Glaxo's super-charged product is the first to show it can confer protection in the event of a pandemic. European regulators have approved it under the brand name Pumarix.
Data shows that children in England who received a similar adjuvanted vaccine during the 2009-10 H1N1 swine flu epidemic had a 14-fold heightened risk of developing narcolepsy, a chronic and potentially debilitating sleep disorder that can cause hallucinations, daytime sleepiness and cataplexy, a form of muscle weakness precipitated by strong emotion.
According to GSK, some 30 million doses of Pandemrix were administered across Europe and 800 people, mostly children, developed narcolepsy. While GSK has acknowledged an association between the vaccine and the narcolepsy cases, it has said there is insufficient evidence to prove the adjuvant was to blame.
Adjuvants have been used in vaccines for diseases such as diphtheria and tetanus for decades. Now, a new, more powerful generation of adjuvants, including one known as AS03 that is contained in the bird flu vaccine, is being developed whose safety is relatively untested. http://cosgarage.com/story.php?title=topic-breast-cancer-causes-and-risk-factors-long-island-bronco-club
Previously, the United States has taken a more cautious approach toward adjuvants than some other countries. The FDA did not, for example, approve Pandemrix for H1NI swine flu. U.S. experts felt that traditional, non-adjuvanted H1N1 vaccines made by Sanofi SA and others offered enough protection against the virus.
But an advisory panel voted unanimously that the FDA should approve the vaccine against bird flu, which kills nearly 60 percent of those who become infected. By comparison, the H1N1 virus kills fewer than 1 percent of those infected.
The H5N1 bird flu virus was first isolated in a human in Hong Kong in 1997 and began to spread throughout Southeast Asia in 2003. A 2011 report by the World Health Organization showed only 566 people had been infected with bird flu worldwide, compared with millions infected with the 2009 H1N1 swine flu virus. But the death rate for bird flu is far higher. http://pongrank.com/story.php?title=topic-bladder-wrack-extracts-an-additional-source-of-organic-iodine-|-|-krybdyrkrybdyr
(Reporting by Toni Clarke; Editing by Leslie Adler)
Friday, 22 November 2013
Will Sleep Therapy Transform Treatment for Depression?
New research being presented this week at a meeting of the Association for Behavioral and Cognitive Therapies will show results that indicate treating insomnia among people with depression may dramatically boost rates of recovery. This is important news and could dramatically change and broaden treatment for millions of people who suffer the debilitating effects of depression.
The study being presented is one of four major research endeavors sponsored by the National Institute of Mental Health and dedicated to furthering our understanding of the impact of disrupted sleep on the course of depression. In particular, this group of studies -- all of which are expected to be published in 2014 -- explores the use of cognitive behavioral therapy for insomnia, often referred to as CBT-I. CBT-I is a form of talk therapy designed specifically to address the sleep disorder. Working regularly with a therapist, patients identify issues, emotions, and behaviors that may impede their sleep. They also learn skills and routines designed to improve sleep. These sleep-improving strategies include: http://campo9news.com/story.php?title=most-helpful-secrets-about-health
Implementing regular bedtimes and wake times.
Developing strong sleep hygiene habits.
Use of relaxation and visualization exercises.
Avoiding naps.
Using sleep restriction to avoid prolonged periods of time spent in bed and awake.
Keeping sleep diaries.
Also critical to the goal of CBT-I is the easing of anxiety and stress about one's ability to fall asleep and to sleep well.
CBT-I has some terrific inherent advantages. It is a relatively low-cost treatment option. The course of treatment often can be a short-term one: once patients receive the help they need to change their approach to sleep, they can stop the therapy and continue to sleep well. CBT-I does not involve the use of prescription sleep aids, a welcome change of direction from the increasing reliance on chemical aids for sleep. A substantial body of research shows that CBT-I can be a highly effective treatment for insomnia, even when the sleep disorder occurs in the presence of another illness or health condition. Studies also suggest that this form of sleep therapy works as well or even better than prescription sleep medications. http://sun955.com/story.php?title=health-news-alert
The results being unveiled this week involve a study of 66 patients with both insomnia and depression. The use of CBT-I to alleviate insomnia appeared to nearly double the rate of recovery from depression, according to the study results being reported. Among the study patients who received four weeks of CBT-I therapy to alleviate their insomnia, 87 percent also had their depression symptoms disappear after eight weeks of treatment. This was nearly twice the number of patients who saw their depression symptoms alleviated without also alleviating their insomnia. If the results of the new research hold up in upcoming studies, sleep therapy may in fact be able to significantly raise the recovery rates for people with depression. http://infoseamore-express.com/story.php?title=health-news-alert
The catalyst for this latest series of investigations into depression and sleep was an earlier study conducted by researchers at Stanford University. This research, published in 2008, included 30 patients with major depressive disorder and insomnia. Patients were all treated with anti-depressant medication, and some were also given seven individual CBT-I sessions, while others were not. Similar to the latest findings, the combination of treatment for depression with CBT-I treatment for insomnia resulted in nearly double the recovery rate from depression symptoms.
The relationship between sleep and depression is complicated. In many ways, science is just beginning to grasp how the two conditions interact and affect one another. In recent years there's been an important change in the fundamental way this relationship is viewed by clinicians and scientists. Where once insomnia and other sleep difficulties were regarded only as a consequence of depression, the sleep disorder is now increasingly recognized as also contributing to depression itself. It is true that depression can and often does interfere with sleep. But the relationship between sleep and depression is now commonly regarded as bi-directional, with each condition capable of influencing the other. A significant body of research indicates that insomnia and other forms of disrupted sleep elevate sharply the risks of depression and other mood disorders. Disordered sleep appears to raise the risk of suicide among depressed patients. And studies indicate that the presence of sleep problems undermines the effectiveness of treatment for depression once diagnosed.
The results of this new sleep-depression research -- the first in a series of studies we'll be seeing results from -- are already being hailed as potentially transformative to the treatment of depression. I am among those eagerly awaiting the full results of this study and the others expected in the coming months. Roughly 19 million U.S. adults are estimated to suffer from depression. Worldwide, that number rises to a staggering 350 million. A significant portion of these people are also likely to be coping with insomnia. Integrating sleep therapy into standard treatment -- a low-cost, non-invasive treatment that may dramatically increase the likelihood of recovery -- could have a profound impact on millions of lives. http://mirocky.com/story.php?title=most-helpful-secrets-to-the-health-for-public
The study being presented is one of four major research endeavors sponsored by the National Institute of Mental Health and dedicated to furthering our understanding of the impact of disrupted sleep on the course of depression. In particular, this group of studies -- all of which are expected to be published in 2014 -- explores the use of cognitive behavioral therapy for insomnia, often referred to as CBT-I. CBT-I is a form of talk therapy designed specifically to address the sleep disorder. Working regularly with a therapist, patients identify issues, emotions, and behaviors that may impede their sleep. They also learn skills and routines designed to improve sleep. These sleep-improving strategies include: http://campo9news.com/story.php?title=most-helpful-secrets-about-health
Implementing regular bedtimes and wake times.
Developing strong sleep hygiene habits.
Use of relaxation and visualization exercises.
Avoiding naps.
Using sleep restriction to avoid prolonged periods of time spent in bed and awake.
Keeping sleep diaries.
Also critical to the goal of CBT-I is the easing of anxiety and stress about one's ability to fall asleep and to sleep well.
CBT-I has some terrific inherent advantages. It is a relatively low-cost treatment option. The course of treatment often can be a short-term one: once patients receive the help they need to change their approach to sleep, they can stop the therapy and continue to sleep well. CBT-I does not involve the use of prescription sleep aids, a welcome change of direction from the increasing reliance on chemical aids for sleep. A substantial body of research shows that CBT-I can be a highly effective treatment for insomnia, even when the sleep disorder occurs in the presence of another illness or health condition. Studies also suggest that this form of sleep therapy works as well or even better than prescription sleep medications. http://sun955.com/story.php?title=health-news-alert
The results being unveiled this week involve a study of 66 patients with both insomnia and depression. The use of CBT-I to alleviate insomnia appeared to nearly double the rate of recovery from depression, according to the study results being reported. Among the study patients who received four weeks of CBT-I therapy to alleviate their insomnia, 87 percent also had their depression symptoms disappear after eight weeks of treatment. This was nearly twice the number of patients who saw their depression symptoms alleviated without also alleviating their insomnia. If the results of the new research hold up in upcoming studies, sleep therapy may in fact be able to significantly raise the recovery rates for people with depression. http://infoseamore-express.com/story.php?title=health-news-alert
The catalyst for this latest series of investigations into depression and sleep was an earlier study conducted by researchers at Stanford University. This research, published in 2008, included 30 patients with major depressive disorder and insomnia. Patients were all treated with anti-depressant medication, and some were also given seven individual CBT-I sessions, while others were not. Similar to the latest findings, the combination of treatment for depression with CBT-I treatment for insomnia resulted in nearly double the recovery rate from depression symptoms.
The relationship between sleep and depression is complicated. In many ways, science is just beginning to grasp how the two conditions interact and affect one another. In recent years there's been an important change in the fundamental way this relationship is viewed by clinicians and scientists. Where once insomnia and other sleep difficulties were regarded only as a consequence of depression, the sleep disorder is now increasingly recognized as also contributing to depression itself. It is true that depression can and often does interfere with sleep. But the relationship between sleep and depression is now commonly regarded as bi-directional, with each condition capable of influencing the other. A significant body of research indicates that insomnia and other forms of disrupted sleep elevate sharply the risks of depression and other mood disorders. Disordered sleep appears to raise the risk of suicide among depressed patients. And studies indicate that the presence of sleep problems undermines the effectiveness of treatment for depression once diagnosed.
The results of this new sleep-depression research -- the first in a series of studies we'll be seeing results from -- are already being hailed as potentially transformative to the treatment of depression. I am among those eagerly awaiting the full results of this study and the others expected in the coming months. Roughly 19 million U.S. adults are estimated to suffer from depression. Worldwide, that number rises to a staggering 350 million. A significant portion of these people are also likely to be coping with insomnia. Integrating sleep therapy into standard treatment -- a low-cost, non-invasive treatment that may dramatically increase the likelihood of recovery -- could have a profound impact on millions of lives. http://mirocky.com/story.php?title=most-helpful-secrets-to-the-health-for-public
U.S. FDA approves J&J hepatitis C pill
(Reuters) - U.S. regulators on Friday approved the use of Johnson & Johnson's Olysio, also known as simeprevir, as a treatment for chronic infection with the liver-destroying hepatitis C virus.
Olysio, a protease inhibitor that blocks a specific protein needed by the virus to replicate, is to be used in combination with interferon, given by injection, and ribavirin, another pill. http://envestx.net/story.php?title=most-helpful-secrets-to-the-health-for-all
Hepatitis C affects about 3.2 million Americans, killing more than 15,000 each year, mostly from illnesses such as cirrhosis and liver cancer. http://www.theedweb.com/story.php?title=health-for-all
The often-undiagnosed virus is transmitted through contaminated blood. Infection rates have dropped since the early 1990s, due in part to the introduction of blood and organ screening. Still, many older adults remain at risk, according to the Centers for Disease Control and Prevention, which has called for baby boomers to be routinely tested for the virus.
Olysio is a member of the same class of drugs as Merck & Co's Victrelis and Vertex Pharmaceuticals' Incivek. The FDA approved both those drugs in 2011.
Olysio was shown in clinical trials to cure patients with a shorter duration of treatment.
Drugmakers have been racing to develop more effective, easier-to-tolerate antivirals to treat hepatitis C. Wall Street analysts have forecast annual sales of billions of dollars for new drugs that would allow doctors to skip use of interferon, which can cause severe flu-like side effects.
The FDA is slated to decide by December 8 on Gilead Sciences' application for sofosbuvir, a member of a different class known as nucleotide analogue inhibitors, or "nukes," designed to block a different enzyme the virus needs to copy itself.
European regulators on Friday recommended approval of the Gilead drug, under the brand name Sovaldi.
Other companies working to develop new hepatitis C drugs include AbbVie and Bristol-Myers Squibb.
http://salonsprite.com/story.php?title=-health-tips-for-new-generation
(Reporting By Deena Beasley)
Olysio, a protease inhibitor that blocks a specific protein needed by the virus to replicate, is to be used in combination with interferon, given by injection, and ribavirin, another pill. http://envestx.net/story.php?title=most-helpful-secrets-to-the-health-for-all
Hepatitis C affects about 3.2 million Americans, killing more than 15,000 each year, mostly from illnesses such as cirrhosis and liver cancer. http://www.theedweb.com/story.php?title=health-for-all
The often-undiagnosed virus is transmitted through contaminated blood. Infection rates have dropped since the early 1990s, due in part to the introduction of blood and organ screening. Still, many older adults remain at risk, according to the Centers for Disease Control and Prevention, which has called for baby boomers to be routinely tested for the virus.
Olysio is a member of the same class of drugs as Merck & Co's Victrelis and Vertex Pharmaceuticals' Incivek. The FDA approved both those drugs in 2011.
Olysio was shown in clinical trials to cure patients with a shorter duration of treatment.
Drugmakers have been racing to develop more effective, easier-to-tolerate antivirals to treat hepatitis C. Wall Street analysts have forecast annual sales of billions of dollars for new drugs that would allow doctors to skip use of interferon, which can cause severe flu-like side effects.
The FDA is slated to decide by December 8 on Gilead Sciences' application for sofosbuvir, a member of a different class known as nucleotide analogue inhibitors, or "nukes," designed to block a different enzyme the virus needs to copy itself.
European regulators on Friday recommended approval of the Gilead drug, under the brand name Sovaldi.
Other companies working to develop new hepatitis C drugs include AbbVie and Bristol-Myers Squibb.
http://salonsprite.com/story.php?title=-health-tips-for-new-generation
(Reporting By Deena Beasley)
U.S. scrambles to boost Obamacare enrollment as deadlines loom
By Roberta Rampton and Sharon Begley
(Reuters) - The Obama administration announced a flurry of fixes to its troubled HealthCare.gov website on Friday that officials said would soon double its current capacity, a crucial step toward getting the system working by a November 30 deadline.
It also pushed back a deadline for people to enroll in insurance plans for 2014 under President Barack Obama's Affordable Care Act in a nod to millions of applicants who have been unable to sign up because of technical glitches for nearly two months.
The healthcare reform, popularly known as Obamacare, aims to provide health benefits to millions of uninsured Americans. Obama's biggest domestic policy achievement, however, has now become one of the biggest political crises of his presidency as polls show Americans increasingly souring on the reform.
As a result, the administration is in a race against time to fix the website, an online insurance exchange, that is central to Obamacare. People need to make decisions on healthcare plans in December if they want insurance in place by January.
People needing health insurance by January 1, 2014 will have eight extra days to sign up, officials said. The original deadline for year-end coverage was December 15, but now will be moved to December 23.
Jeffrey Zients, the troubleshooter named by Obama to oversee fixes to HealthCare.gov told reporters on Friday that the website will soon be able to handle 50,000 simultaneous users - twice its current capacity, and up from fewer than 1,000 in the days after its botched launch on Oct 1.
The website will be able to handle 800,000 people per day by the end of November, Zients said, largely because of more than 300 software and other fixes made to the site in the past seven weeks, and because of a doubling in the system's hardware capacity, which will happen this weekend.
DIRECT ENROLLMENT
Some of the technical fixes will allow insurance companies to more easily directly enroll consumers in health plans, a senior administration official said.
The administration will run a pilot program for direct enrollment in three states with large numbers of uninsured people - Texas, Florida and Ohio - and use the results to expand the availability of the "direct enrollment" option.
"We do believe that it's substantial. We're looking at hundreds of thousands of people who we believe may well opt to do this," the official told Reuters.
Insurance companies worked with the administration to address the technical challenges in the direct enrollment option, said Robert Zirkelbach, spokesman for America's Health Insurance Plans, a lobby group.
"Getting direct enrollment working will enable health plans to do what they do best, and that's enroll people in coverage," Zirkelbach said.
Greg Thompson, a spokesman for Health Care Service Corporation, which operates health plans including Blue Cross Blue Shield of Texas, said he did not immediately know whether the Texas plan would participate in the pilot project.
"We are looking at a variety of ways that people can have access to enrollment," Thompson said. "We want to make sure it can happen both on and off the exchanges."
DELAY FOR YEAR TWO
Officials were adamant that they have no plans to extend the ultimate deadline of March 31, 2014, the date when people without insurance must enroll in a plan or face a tax penalty.
But with the first enrollment period barely off the ground, the Obama administration also has decided to delay enrollment for the second year of the program to give insurance companies more time to calculate rates, White House spokesman Jay Carney told reporters.
The delay will mean consumers will start shopping for insurance for Year Two of Obamacare on November 15, 2014 - more than a week after voters go to the polls for midterm elections, when congressional Democrats are expected to face tough questions about the policy they supported. http://unleashedsolar.net/story.php?title=most-helpful-secrets-to-the-health-for-all
"That means that if premiums go through the roof in the first year of Obamacare, no one will know about it until after the election," said Republican Senator Charles Grassley of Iowa.
But Carney rejected any assertion that politics was behind the extension.
"The fact is, we're doing it because it make sense for insurers to have as clear a sense of the pool of consumers they gain in the market this year, before setting rates for next year," Carney said. http://totaldealerspendcanada.biz/story.php?title=most-helpful-secrets-to-the-health-for-all
(Reporting by Roberta Rampton in Washington and Sharon Begley in New York; Additional reporting by Jeff Mason, Steve Holland, Caroline Humer and Lewis Krauskopf; Editing by Fred Barbash, Ross Colvin, Grant McCool and Eric Walsh) http://knitting-iceland.net/story.php?title=most-helpful-secrets-to-the-health-for-all
(Reuters) - The Obama administration announced a flurry of fixes to its troubled HealthCare.gov website on Friday that officials said would soon double its current capacity, a crucial step toward getting the system working by a November 30 deadline.
It also pushed back a deadline for people to enroll in insurance plans for 2014 under President Barack Obama's Affordable Care Act in a nod to millions of applicants who have been unable to sign up because of technical glitches for nearly two months.
The healthcare reform, popularly known as Obamacare, aims to provide health benefits to millions of uninsured Americans. Obama's biggest domestic policy achievement, however, has now become one of the biggest political crises of his presidency as polls show Americans increasingly souring on the reform.
As a result, the administration is in a race against time to fix the website, an online insurance exchange, that is central to Obamacare. People need to make decisions on healthcare plans in December if they want insurance in place by January.
People needing health insurance by January 1, 2014 will have eight extra days to sign up, officials said. The original deadline for year-end coverage was December 15, but now will be moved to December 23.
Jeffrey Zients, the troubleshooter named by Obama to oversee fixes to HealthCare.gov told reporters on Friday that the website will soon be able to handle 50,000 simultaneous users - twice its current capacity, and up from fewer than 1,000 in the days after its botched launch on Oct 1.
The website will be able to handle 800,000 people per day by the end of November, Zients said, largely because of more than 300 software and other fixes made to the site in the past seven weeks, and because of a doubling in the system's hardware capacity, which will happen this weekend.
DIRECT ENROLLMENT
Some of the technical fixes will allow insurance companies to more easily directly enroll consumers in health plans, a senior administration official said.
The administration will run a pilot program for direct enrollment in three states with large numbers of uninsured people - Texas, Florida and Ohio - and use the results to expand the availability of the "direct enrollment" option.
"We do believe that it's substantial. We're looking at hundreds of thousands of people who we believe may well opt to do this," the official told Reuters.
Insurance companies worked with the administration to address the technical challenges in the direct enrollment option, said Robert Zirkelbach, spokesman for America's Health Insurance Plans, a lobby group.
"Getting direct enrollment working will enable health plans to do what they do best, and that's enroll people in coverage," Zirkelbach said.
Greg Thompson, a spokesman for Health Care Service Corporation, which operates health plans including Blue Cross Blue Shield of Texas, said he did not immediately know whether the Texas plan would participate in the pilot project.
"We are looking at a variety of ways that people can have access to enrollment," Thompson said. "We want to make sure it can happen both on and off the exchanges."
DELAY FOR YEAR TWO
Officials were adamant that they have no plans to extend the ultimate deadline of March 31, 2014, the date when people without insurance must enroll in a plan or face a tax penalty.
But with the first enrollment period barely off the ground, the Obama administration also has decided to delay enrollment for the second year of the program to give insurance companies more time to calculate rates, White House spokesman Jay Carney told reporters.
The delay will mean consumers will start shopping for insurance for Year Two of Obamacare on November 15, 2014 - more than a week after voters go to the polls for midterm elections, when congressional Democrats are expected to face tough questions about the policy they supported. http://unleashedsolar.net/story.php?title=most-helpful-secrets-to-the-health-for-all
"That means that if premiums go through the roof in the first year of Obamacare, no one will know about it until after the election," said Republican Senator Charles Grassley of Iowa.
But Carney rejected any assertion that politics was behind the extension.
"The fact is, we're doing it because it make sense for insurers to have as clear a sense of the pool of consumers they gain in the market this year, before setting rates for next year," Carney said. http://totaldealerspendcanada.biz/story.php?title=most-helpful-secrets-to-the-health-for-all
(Reporting by Roberta Rampton in Washington and Sharon Begley in New York; Additional reporting by Jeff Mason, Steve Holland, Caroline Humer and Lewis Krauskopf; Editing by Fred Barbash, Ross Colvin, Grant McCool and Eric Walsh) http://knitting-iceland.net/story.php?title=most-helpful-secrets-to-the-health-for-all
Planned Parenthood clinic in Austin, Texas, resumes abortion services
By Lisa Maria Garza
DALLAS (Reuters) - A Planned Parenthood clinic in Austin, Texas, resumed abortion services on Friday under strict new state rules, the organization said, but 11 other abortion clinics in the state are still not performing the procedure.http://delawarejudges.org/story.php?title=good-health-for-all
Planned Parenthood said its Austin doctor had received admitting privileges at a nearby hospital, a requirement under the new law. The clinic had closed on October 31 when the law was enacted after a federal appeals court overturned a lower-court ruling that said the law was an undue burden on women seeking abortions. http://thecooperbuilding.net/story.php?title=most-helpful-secrets-to-the-health-for-all
"While we are thrilled that we are able to resume providing women with abortion in Austin - health services that have been their constitutional right for 40 years - there are still women throughout the state that have no option available," Planned Parenthood of Greater Texas spokeswoman Sarah Wheat said in a statement.
The provision requires doctors to have an agreement with a hospital within 30 miles of the facility in case women have complications because of an abortion procedure.http://totalsponsorship.net/story.php?title=most-helpful-secrets-to-the-health-for-all
A divided U.S. Supreme Court declined on Tuesday to block implementation of the new law.
Eleven of the 32 abortion clinics in the state have stopped performing the procedure due to the law.
Planned Parenthood said its facilities in Waco and Fort Worth remained closed.
Reproductive Services in El Paso should know by December 1 if its application to admit any patients at a nearby hospital is approved, administrator Gerri Laster said.
A ban on abortions in Texas after 20 weeks gestation went into effect last month. A requirement that facilities where abortions are performed meet the standards of hospital emergency centers is set to take effect next year.
(Reporting by Lisa Maria Garza; Editing by Ian Simpson and Eric Beech)
DALLAS (Reuters) - A Planned Parenthood clinic in Austin, Texas, resumed abortion services on Friday under strict new state rules, the organization said, but 11 other abortion clinics in the state are still not performing the procedure.http://delawarejudges.org/story.php?title=good-health-for-all
Planned Parenthood said its Austin doctor had received admitting privileges at a nearby hospital, a requirement under the new law. The clinic had closed on October 31 when the law was enacted after a federal appeals court overturned a lower-court ruling that said the law was an undue burden on women seeking abortions. http://thecooperbuilding.net/story.php?title=most-helpful-secrets-to-the-health-for-all
"While we are thrilled that we are able to resume providing women with abortion in Austin - health services that have been their constitutional right for 40 years - there are still women throughout the state that have no option available," Planned Parenthood of Greater Texas spokeswoman Sarah Wheat said in a statement.
The provision requires doctors to have an agreement with a hospital within 30 miles of the facility in case women have complications because of an abortion procedure.http://totalsponsorship.net/story.php?title=most-helpful-secrets-to-the-health-for-all
A divided U.S. Supreme Court declined on Tuesday to block implementation of the new law.
Eleven of the 32 abortion clinics in the state have stopped performing the procedure due to the law.
Planned Parenthood said its facilities in Waco and Fort Worth remained closed.
Reproductive Services in El Paso should know by December 1 if its application to admit any patients at a nearby hospital is approved, administrator Gerri Laster said.
A ban on abortions in Texas after 20 weeks gestation went into effect last month. A requirement that facilities where abortions are performed meet the standards of hospital emergency centers is set to take effect next year.
(Reporting by Lisa Maria Garza; Editing by Ian Simpson and Eric Beech)
Subscribe to:
Posts (Atom)